Jennison Associates’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$76.7M Buy
1,318,814
+26,759
+2% +$1.23M 0.05% 166
2025
Q4
$57.9M Buy
1,292,055
+156,820
+14% +$6.59M 0.03% 192
2025
Q3
$45.6M Buy
1,135,235
+438,852
+63% +$15.5M 0.03% 228
2025
Q2
$21.8M Sell
696,383
-80,310
-10% -$2.62M 0.01% 325
2025
Q1
$26.1M Sell
776,693
-24,860
-3% -$944K 0.02% 302
2024
Q4
$31.4M Buy
801,553
+224,892
+39% +$9.3M 0.02% 291
2024
Q3
$22.7M Buy
576,661
+6,389
+1% +$258K 0.01% 328
2024
Q2
$22.2M Buy
570,272
+6,320
+1% +$253K 0.01% 317
2024
Q1
$24.3M Sell
563,952
-2,444
-0.4% -$112K 0.02% 324
2023
Q4
$26.1M Buy
566,396
+352,573
+165% +$12.5M 0.02% 299
2023
Q3
$7.3M Buy
213,823
+25,432
+13% +$951K 0.01% 391
2023
Q2
$7.25M Buy
+188,391
New +$7.49M 0.01% 400

Other funds holding XENE